Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Ventas, Inc.VTR · Entity 3044 | Director | April 18, 2024 | April 22, 2024 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Ventas, Inc.
Report date April 18, 2024 · Filed April 22, 2024
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 72,422.789 |
Reported balance
After 2024-04-18 transaction · row 1
1 source rowRow 1 · 2024-04-18 · Grant · Acquired 261.487 · Balance 72,422.789 F1: Common stock in the form of units granted under the Ventas Non-Employee Directors' Cash Compensation Deferral Plan (the "Plan") as a result of dividend equivalents credited with respect to the dividend on Issuer's common stock paid on January 18, 2024. Such units are payable solely in common stock and subject to the terms and conditions of the Reporting Person's deferral election and the Plan. F2: Represents the closing price per share of Issuer's common stock as of the date of the grant. |
Filing footnotes · ownership attribution and instrument terms
F1: Common stock in the form of units granted under the Ventas Non-Employee Directors' Cash Compensation Deferral Plan (the "Plan") as a result of dividend equivalents credited with respect to the dividend on Issuer's common stock paid on January 18, 2024. Such units are payable solely in common stock and subject to the terms and conditions of the Reporting Person's deferral election and the Plan.
F2: Represents the closing price per share of Issuer's common stock as of the date of the grant.
Past disclosures · reporting ended (2)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
Envision Healthcare Corp
Report date October 11, 2018 · Filed October 15, 2018
Section 16 reporting ended · disclosed 2018-10-15. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 0 |
Reported balance
After 2018-10-11 transaction · row 1
1 source rowRow 1 · 2018-10-11 · Disposition to issuer · Disposed 13,553 · Balance 0 F1: At the Effective Time, each share of common stock, par value $0.01 per share, of the Company ("Company Common Stock") that was outstanding immediately prior to the Effective Time (other than certain shares specified in the Merger Agreement) was cancelled and converted into the right to receive $46.00 in cash, (the "Merger Consideration") without interest and subject to applicable withholding taxes. F2: Includes 13,553 restricted stock unit awards ("Company RSUs"). At the Effective Time, each Company RSU that was outstanding as of immediately prior to the Effective Time was converted into the right to receive an amount in cash equal to the sum of (i) the product of (A) the total number of shares of Company Common Stock subject to such Company RSU immediately prior to the Effective Time and (B) the Merger Consideration and (ii) any accrued but unpaid dividend equivalents with respect to such Company RSU. |
Filing footnotes · ownership attribution and instrument terms
F1: At the Effective Time, each share of common stock, par value $0.01 per share, of the Company ("Company Common Stock") that was outstanding immediately prior to the Effective Time (other than certain shares specified in the Merger Agreement) was cancelled and converted into the right to receive $46.00 in cash, (the "Merger Consideration") without interest and subject to applicable withholding taxes.
F2: Includes 13,553 restricted stock unit awards ("Company RSUs"). At the Effective Time, each Company RSU that was outstanding as of immediately prior to the Effective Time was converted into the right to receive an amount in cash equal to the sum of (i) the product of (A) the total number of shares of Company Common Stock subject to such Company RSU immediately prior to the Effective Time and (B) the Merger Consideration and (ii) any accrued but unpaid dividend equivalents with respect to such Company RSU.
Envision Healthcare Holdings, Inc.
Report date December 01, 2016 · Filed December 01, 2016
Section 16 reporting ended · disclosed 2016-12-01. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 0 |
Reported balance
After 2016-12-01 transaction · row 1
1 source rowRow 1 · 2016-12-01 · Disposition to issuer · Disposed 10,435 · Balance 0 F1: Disposition pursuant to the terms of the Agreement and Plan of Merger, dated as of June 15, 2016, by and among Envision Healthcare Holdings, Inc., New Amethyst Corp. and AmSurg Corp. (the "Merger Agreement"), exempt under Rule 16b-3. F2: Pursuant to the terms of the Merger Agreement, at the Merger 2 Effective Time, each deferred stock unit held by the reporting person immediately prior to the Merger 2 Effective Time (as defined in the Merger Agreement) was assumed by New Amethyst and converted into a New Amethyst deferred stock unit having the same terms and conditions, taking into account any changes thereto by reason of the Mergers (as defined in the Merger Agreement). |
Filing footnotes · ownership attribution and instrument terms
F1: Disposition pursuant to the terms of the Agreement and Plan of Merger, dated as of June 15, 2016, by and among Envision Healthcare Holdings, Inc., New Amethyst Corp. and AmSurg Corp. (the "Merger Agreement"), exempt under Rule 16b-3.
F2: Pursuant to the terms of the Merger Agreement, at the Merger 2 Effective Time, each deferred stock unit held by the reporting person immediately prior to the Merger 2 Effective Time (as defined in the Merger Agreement) was assumed by New Amethyst and converted into a New Amethyst deferred stock unit having the same terms and conditions, taking into account any changes thereto by reason of the Mergers (as defined in the Merger Agreement).
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| October 11, 2019 Filed Oct 11, 2019 20:50 UTC | Ventas, Inc. VTR · Entity 3044 | GrantCommon Stock | 143.203 | $72.13 | $10,329.23 |
DisclosureSEC source: 0000740260-19-000162 · wf-form4_157082701692873.xml · nonDerivative · entry 1 SHELTON JAMES D · CIK 0001188136 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 45,087.963 F1 · shares: Common stock in the form of units granted under the Ventas Nonemployee Directors' Deferred Stock Compensation Plan (the "Plan") as a result of dividend equivalents credited with respect to the dividend on Issuer's common stock paid on October 11, 2019. Such units are payable solely in common stock and subject to the terms and conditions of the director's deferral election and the Plan. F2 · balance_after: As of October 11, 2019, Reporting Person owns options to purchase an aggregate of 11,880 shares of Issuer's common stock. Read SEC document |
| October 01, 2019 Filed Oct 2, 2019 20:40 UTC | Ventas, Inc. VTR · Entity 3044 | GrantCommon Stock | 301.475 | $72.56 | $21,875.03 |
DisclosureSEC source: 0000740260-19-000153 · wf-form4_157004881397979.xml · nonDerivative · entry 1 SHELTON JAMES D · CIK 0001188136 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 44,944.76 F1 · shares: Common stock in the form of units granted under the Ventas Nonemployee Directors' Deferred Stock Compensation Plan (the "Plan") in lieu of director fees pursuant to the director's deferral election. Such units are payable solely in common stock and subject to the terms and conditions of the director's deferral election and the Plan. F2 · balance_after: As of October 1, 2019, Reporting Person owns options to purchase an aggregate of 11,880 shares of Issuer's common stock. Read SEC document |
| July 12, 2019 Filed Jul 16, 2019 20:39 UTC | Ventas, Inc. VTR · Entity 3044 | GrantCommon Stock | 144.328 | $69.12 | $9,975.95 |
DisclosureSEC source: 0000740260-19-000130 · wf-form4_156330952543838.xml · nonDerivative · entry 1 SHELTON JAMES D · CIK 0001188136 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 44,643.285 F1 · shares: Common stock in the form of units granted under the Ventas Nonemployee Directors' Deferred Stock Compensation Plan (the "Plan") as a result of dividend equivalents credited with respect to the dividend on Issuer's common stock paid on July 12, 2019. Such units are payable solely in common stock and subject to the terms and conditions of the director's deferral election and the Plan. F2 · balance_after: As of July 12, 2019, Reporting Person owns options to purchase an aggregate of 11,880 shares of Issuer's common stock. Read SEC document |
| July 01, 2019 Filed Jul 2, 2019 20:37 UTC | Ventas, Inc. VTR · Entity 3044 | GrantCommon Stock | 322.118 | $67.91 | $21,875.03 |
DisclosureSEC source: 0000740260-19-000121 · wf-form4_156209984276617.xml · nonDerivative · entry 1 SHELTON JAMES D · CIK 0001188136 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 44,498.957 F1 · shares: Common stock in the form of units granted under the Ventas Nonemployee Directors' Deferred Stock Compensation Plan (the "Plan") in lieu of director fees pursuant to the director's deferral election. Such units are payable solely in common stock and subject to the terms and conditions of the director's deferral election and the Plan. F2 · balance_after: As of July 1, 2019, Reporting Person owns options to purchase an aggregate of 11,880 shares of Issuer's common stock. Read SEC document |
| May 14, 2019 Filed May 16, 2019 20:32 UTC | Ventas, Inc. VTR · Entity 3044 | GrantCommon Stock | 2,756 | $63.49 | $174,978.44 |
DisclosureSEC source: 0000740260-19-000095 · wf-form4_155803875811791.xml · nonDerivative · entry 1 SHELTON JAMES D · CIK 0001188136 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 44,176.839 F1 · shares: Restricted stock units granted by Issuer pursuant to the Ventas, Inc. 2012 Incentive Plan (the "Plan"). Such units are payable solely in common stock and subject to the terms and conditions of the director's deferral election and the Plan. These restricted stock units vest in two equal annual installments on the date of the Issuer's 2020 Annual Meeting of Stockholders and the date of the Issuer's 2021 Annual Meeting of Stockholders. F2 · balance_after: As of May 14, 2019, Reporting Person owns options to purchase an aggregate of 11,880 shares of Issuer's common stock. Read SEC document |
| April 12, 2019 Filed Apr 15, 2019 20:40 UTC | Ventas, Inc. VTR · Entity 3044 | GrantCommon Stock | 154.732 | $62.03 | $9,598.03 |
DisclosureSEC source: 0000740260-19-000077 · wf-form4_155536082562490.xml · nonDerivative · entry 1 SHELTON JAMES D · CIK 0001188136 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 41,420.839 F1 · shares: Common stock in the form of units granted under the Ventas Nonemployee Directors' Deferred Stock Compensation Plan (the "Plan") as a result of dividend equivalents credited with respect to the dividend on Issuer's common stock paid on April 12, 2019. Such units are payable solely in common stock and subject to the terms and conditions of the director's deferral election and the Plan. F2 · balance_after: As of April 12, 2019, Reporting Person owns options to purchase an aggregate of 11,880 shares of Issuer's common stock. Read SEC document |
| April 01, 2019 Filed Apr 2, 2019 20:40 UTC | Ventas, Inc. VTR · Entity 3044 | GrantCommon Stock | 345.795 | $63.26 | $21,874.99 |
DisclosureSEC source: 0000740260-19-000067 · wf-form4_155423761007793.xml · nonDerivative · entry 1 SHELTON JAMES D · CIK 0001188136 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 41,266.107 F1 · shares: Common stock in the form of units granted under the Ventas Nonemployee Directors' Deferred Stock Compensation Plan (the "Plan") in lieu of director fees pursuant to the director's deferral election. Such units are payable solely in common stock and subject to the terms and conditions of the director's deferral election and the Plan. F2 · balance_after: As of April 1, 2019, Reporting Person owns options to purchase an aggregate of 11,880 shares of Issuer's common stock. Read SEC document |
| March 28, 2019 Filed Mar 29, 2019 20:49 UTC | Ventas, Inc. VTR · Entity 3044 | Exercise / conversionStock Option (Right to Buy) · Derivative | 5,940 | $36.82 Strike: $36.82 | $218,710.80 |
DisclosureSEC source: 0000740260-19-000060 · wf-form4_155389257581205.xml · derivative · entry 3 SHELTON JAMES D · CIK 0001188136 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,880 Underlying: Common Stock · 5,940 shares Expires 2020-01-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: These options vested in two equal annual installments beginning on the date of grant. Read SEC document |
| March 28, 2019 Filed Mar 29, 2019 20:49 UTC | Ventas, Inc. VTR · Entity 3044 | SaleCommon Stock | 5,940 | $64.79 | $384,868.64 |
DisclosureSEC source: 0000740260-19-000060 · wf-form4_155389257581205.xml · nonDerivative · entry 2 SHELTON JAMES D · CIK 0001188136 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,920.312 F1 · shares: On March 28, 2019, the Reporting Person transmitted to the Securities and Exchange Commission (the "SEC") a Form 144 covering the sale of the Issuer's common stock reported in Table I. The price reported in column 4 is a weighted average price. These shares were sold by the Reporting Person in multiple transactions at prices ranging from $64.50 to $65.26, inclusive. The Reporting Person undertakes to provide Issuer, any security holder of Issuer or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (1). Read SEC document |
| March 28, 2019 Filed Mar 29, 2019 20:49 UTC | Ventas, Inc. VTR · Entity 3044 | Exercise / conversionCommon Stock | 5,940 | $36.82 | $218,710.80 |
DisclosureSEC source: 0000740260-19-000060 · wf-form4_155389257581205.xml · nonDerivative · entry 1 SHELTON JAMES D · CIK 0001188136 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 46,860.312 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 14, 2019 Filed Jan 15, 2019 21:40 UTC | Ventas, Inc. VTR · Entity 3044 | GrantCommon Stock | 153.173 | $60.08 | $9,202.63 |
DisclosureSEC source: 0000740260-19-000016 · wf-form4_154758839100318.xml · nonDerivative · entry 1 SHELTON JAMES D · CIK 0001188136 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,920.312 F1 · shares: Common stock in the form of units granted under the Ventas Nonemployee Directors' Deferred Stock Compensation Plan (the "Plan") as a result of dividend equivalents credited with respect to the dividend on Issuer's common stock paid on January 14, 2019. Such units are payable solely in common stock and subject to the terms and conditions of the director's deferral election and the Plan. F2 · balance_after: As of January 14, 2019, Reporting Person owns options to purchase an aggregate of 17,820 shares of Issuer's common stock. Read SEC document |
| January 01, 2019 Filed Jan 2, 2019 21:40 UTC | Ventas, Inc. VTR · Entity 3044 | GrantCommon Stock | 362.69 | $58.59 | $21,250.01 |
DisclosureSEC source: 0000740260-19-000005 · wf-form4_154646519632183.xml · nonDerivative · entry 1 SHELTON JAMES D · CIK 0001188136 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,767.139 F1 · shares: Common stock in the form of units granted under the Ventas Nonemployee Directors' Deferred Stock Compensation Plan (the "Plan") in lieu of director fees pursuant to the director's deferral election. Such units are payable solely in common stock and subject to the terms and conditions of the director's deferral election and the Plan. F2 · balance_after: As of January 1, 2019, Reporting Person owns options to purchase an aggregate of 17,820 shares of Issuer's common stock. Read SEC document |
| November 28, 2018 Filed Nov 29, 2018 21:31 UTC | Ventas, Inc. VTR · Entity 3044 | Exercise / conversionStock Option (Right to Buy) · Derivative | 5,940 | $28.26 Strike: $28.26 | $167,864.40 |
DisclosureSEC source: 0000740260-18-000183 · wf-form4_154352704648630.xml · derivative · entry 2 SHELTON JAMES D · CIK 0001188136 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,820 Underlying: Common Stock · 5,940 shares Expires 2019-01-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: These options vested in two equal annual installments beginning on January 1, 2009. Read SEC document |
| November 28, 2018 Filed Nov 29, 2018 21:31 UTC | Ventas, Inc. VTR · Entity 3044 | Exercise / conversionCommon Stock | 5,940 | $28.26 | $167,864.40 |
DisclosureSEC source: 0000740260-18-000183 · wf-form4_154352704648630.xml · nonDerivative · entry 1 SHELTON JAMES D · CIK 0001188136 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,404.449 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| October 12, 2018 Filed Oct 15, 2018 20:49 UTC | Ventas, Inc. VTR · Entity 3044 | GrantCommon Stock | 164.271 | $53.31 | $8,757.29 |
DisclosureSEC source: 0000740260-18-000171 · wf-form4_153963653402243.xml · nonDerivative · entry 1 SHELTON JAMES D · CIK 0001188136 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 34,464.449 F1 · shares: Common stock in the form of units granted under the Ventas Nonemployee Directors' Deferred Stock Compensation Plan (the "Plan") as a result of dividend equivalents credited with respect to the dividend on Issuer's common stock paid on October 12, 2018. Such units are payable solely in common stock and subject to the terms and conditions of the director's deferral election and the Plan. F2 · balance_after: As of October 12, 2018, Reporting Person owns options to purchase an aggregate of 23,760 shares of Issuer's common stock. Read SEC document |
| October 11, 2018 Filed Oct 15, 2018 12:55 UTC | Envision Healthcare Corp EVHC · Entity 162981 | Disposition to issuerCommon Stock | 13,553 | $46.00 | $623,438.00 |
DisclosureSEC source: 0001678531-18-000154 · wf-form4_153962253179349.xml · nonDerivative · entry 1 SHELTON JAMES D · CIK 0001188136 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · shares: At the Effective Time, each share of common stock, par value $0.01 per share, of the Company ("Company Common Stock") that was outstanding immediately prior to the Effective Time (other than certain shares specified in the Merger Agreement) was cancelled and converted into the right to receive $46.00 in cash, (the "Merger Consideration") without interest and subject to applicable withholding taxes. F2 · shares: Includes 13,553 restricted stock unit awards ("Company RSUs"). At the Effective Time, each Company RSU that was outstanding as of immediately prior to the Effective Time was converted into the right to receive an amount in cash equal to the sum of (i) the product of (A) the total number of shares of Company Common Stock subject to such Company RSU immediately prior to the Effective Time and (B) the Merger Consideration and (ii) any accrued but unpaid dividend equivalents with respect to such Company RSU. F1 · price: At the Effective Time, each share of common stock, par value $0.01 per share, of the Company ("Company Common Stock") that was outstanding immediately prior to the Effective Time (other than certain shares specified in the Merger Agreement) was cancelled and converted into the right to receive $46.00 in cash, (the "Merger Consideration") without interest and subject to applicable withholding taxes. Read SEC document |
| October 01, 2018 Filed Oct 2, 2018 20:44 UTC | Ventas, Inc. VTR · Entity 3044 | GrantCommon Stock | 393.664 | $53.98 | $21,249.98 |
DisclosureSEC source: 0000740260-18-000161 · wf-form4_153851308102388.xml · nonDerivative · entry 1 SHELTON JAMES D · CIK 0001188136 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 34,300.178 F1 · shares: Common stock in the form of units granted under the Ventas Nonemployee Directors' Deferred Stock Compensation Plan (the "Plan") in lieu of director fees pursuant to the director's deferral election. Such units are payable solely in common stock and subject to the terms and conditions of the director's deferral election and the Plan. F2 · balance_after: As of October 1, 2018, Reporting Person owns options to purchase an aggregate of 23,760 shares of Issuer's common stock. Read SEC document |
| July 12, 2018 Filed Jul 13, 2018 20:40 UTC | Ventas, Inc. VTR · Entity 3044 | GrantCommon Stock | 142.698 | $58.40 | $8,333.56 |
DisclosureSEC source: 0000740260-18-000140 · wf-form4_153151442811002.xml · nonDerivative · entry 1 SHELTON JAMES D · CIK 0001188136 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 33,906.514 F1 · shares: Common stock in the form of units granted under the Ventas Nonemployee Directors' Deferred Stock Compensation Plan (the "Plan") as a result of dividend equivalents credited with respect to the dividend on Issuer's common stock paid on July 12, 2018. Such units are payable solely in common stock and subject to the terms and conditions of the director's deferral election and the Plan. F2 · balance_after: As of July 12, 2018, Reporting Person owns options to purchase an aggregate of 23,760 shares of Issuer's common stock. Read SEC document |
| July 06, 2018 Filed Jul 9, 2018 17:21 UTC | Envision Healthcare Corp EVHC · Entity 162981 | GrantCommon Stock | 524 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001678531-18-000089 · wf-form4_153117125134104.xml · nonDerivative · entry 1 SHELTON JAMES D · CIK 0001188136 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,592 F1 · shares: Represents vested deferred stock units granted, pursuant to the Reporting Person's election, in lieu of $23,125 in cash for director fees. These deferred stock units will be settled into an equal number of shares of common stock following the earlier of the Reporting Person's termination of board service and a change in control under the Envision Healthcare Corporation 2013 Omnibus Incentive Plan. F1 · price: Represents vested deferred stock units granted, pursuant to the Reporting Person's election, in lieu of $23,125 in cash for director fees. These deferred stock units will be settled into an equal number of shares of common stock following the earlier of the Reporting Person's termination of board service and a change in control under the Envision Healthcare Corporation 2013 Omnibus Incentive Plan. Read SEC document |
| July 01, 2018 Filed Jul 2, 2018 20:30 UTC | Ventas, Inc. VTR · Entity 3044 | GrantCommon Stock | 373.134 | $56.95 | $21,249.98 |
DisclosureSEC source: 0000740260-18-000126 · wf-form4_153056339808264.xml · nonDerivative · entry 1 SHELTON JAMES D · CIK 0001188136 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 33,763.816 F1 · shares: Common stock in the form of units granted under the Ventas Nonemployee Directors' Deferred Stock Compensation Plan (the "Plan") in lieu of director fees pursuant to the director's deferral election. Such units are payable solely in common stock and subject to the terms and conditions of the director's deferral election and the Plan. F2 · balance_after: As of July 1, 2018, Reporting Person owns options to purchase an aggregate of 23,760 shares of Issuer's common stock. Read SEC document |
| May 25, 2018 Filed May 29, 2018 18:20 UTC | Envision Healthcare Corp EVHC · Entity 162981 | GrantCommon Stock | 4,017 | $43.57 | $175,020.69 |
DisclosureSEC source: 0001678531-18-000086 · wf-form4_152763234164999.xml · nonDerivative · entry 1 SHELTON JAMES D · CIK 0001188136 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,068 F1 · kind: Represents deferred stock units granted, pursuant to the Reporting Person's election, in lieu of the annual restricted stock unit award to non-employee directors for service on the Company's board of directors (the "Board"). The deferred stock units vest on the earlier of (i) the one-year anniversary of the grant date or (ii) the date of the Company's next annual shareholders meeting, in each case subject to continued service on the Board. Pursuant to the Reporting Person's election, once vested the settlement of these deferred stock units will be deferred until the earlier of the Reporting Person's termination of board service and a change in control of the Company. Read SEC document |
| May 15, 2018 Filed May 16, 2018 20:50 UTC | Ventas, Inc. VTR · Entity 3044 | GrantCommon Stock | 3,157 | $52.26 | $164,984.82 |
DisclosureSEC source: 0000740260-18-000109 · wf-form4_152650381473685.xml · nonDerivative · entry 1 SHELTON JAMES D · CIK 0001188136 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 33,390.682 F1 · shares: Restricted stock units granted by Issuer pursuant to the Ventas, Inc. 2012 Incentive Plan (the "Plan"). Such units are payable solely in common stock and subject to the terms and conditions of the director's deferral election and the Plan. These restricted stock units vest in two equal annual installments on the date of the Issuer's 2019 Annual Meeting of Stockholders and the date of the Issuer's 2020 Annual Meeting of Stockholders. F2 · balance_after: As of May 15, 2018, Reporting Person owns options to purchase an aggregate of 23,760 shares of Issuer's common stock. Read SEC document |
| April 12, 2018 Filed Apr 16, 2018 21:40 UTC | Ventas, Inc. VTR · Entity 3044 | GrantCommon Stock | 163.59 | $48.35 | $7,909.58 |
DisclosureSEC source: 0000740260-18-000086 · wf-form4_152391483352846.xml · nonDerivative · entry 1 SHELTON JAMES D · CIK 0001188136 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,233.682 F1 · shares: Common stock in the form of units granted under the Ventas Nonemployee Directors' Deferred Stock Compensation Plan (the "Plan") as a result of dividend equivalents credited with respect to the dividend on Issuer's common stock paid on April 12, 2018. Such units are payable solely in common stock and subject to the terms and conditions of the director's deferral election and the Plan. F2 · balance_after: As of April 12, 2018, Reporting Person owns options to purchase an aggregate of 23,760 shares of Issuer's common stock. Read SEC document |
| April 06, 2018 Filed Apr 10, 2018 16:43 UTC | Envision Healthcare Corp EVHC · Entity 162981 | GrantCommon Stock | 612 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001678531-18-000059 · wf-form4_152339300494596.xml · nonDerivative · entry 1 SHELTON JAMES D · CIK 0001188136 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,051 F1 · shares: Represents vested deferred stock units granted, pursuant to the Reporting Person's election, in lieu of $23,125 in cash for director fees. These deferred stock units will be settled into an equal number of shares of common stock following the earlier of the Reporting Person's termination of board service and a change in control under the Envision Healthcare Corporation 2013 Omnibus Incentive Plan. F1 · price: Represents vested deferred stock units granted, pursuant to the Reporting Person's election, in lieu of $23,125 in cash for director fees. These deferred stock units will be settled into an equal number of shares of common stock following the earlier of the Reporting Person's termination of board service and a change in control under the Envision Healthcare Corporation 2013 Omnibus Incentive Plan. Read SEC document |
| April 01, 2018 Filed Apr 3, 2018 20:57 UTC | Ventas, Inc. VTR · Entity 3044 | GrantCommon Stock | 429.033 | $49.53 | $21,250.00 |
DisclosureSEC source: 0000740260-18-000069 · wf-form4_152278905162340.xml · nonDerivative · entry 1 SHELTON JAMES D · CIK 0001188136 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,070.092 F1 · shares: Common stock in the form of units granted under the Ventas Nonemployee Directors' Deferred Stock Compensation Plan (the "Plan") in lieu of director fees pursuant to the director's deferral election. Such units are payable solely in common stock and subject to the terms and conditions of the director's deferral election and the Plan. F2 · balance_after: As of April 1, 2018, Reporting Person owns options to purchase an aggregate of 23,760 shares of Issuer's common stock. Read SEC document |
| January 12, 2018 Filed Jan 16, 2018 22:00 UTC | Ventas, Inc. VTR · Entity 3044 | GrantCommon Stock | 136.113 | $54.83 | $7,463.08 |
DisclosureSEC source: 0000740260-18-000020 · wf-form4_151613999932897.xml · nonDerivative · entry 1 SHELTON JAMES D · CIK 0001188136 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,641.059 F1 · shares: Common stock in the form of units granted under the Ventas Nonemployee Directors' Deferred Stock Compensation Plan (the "Plan") as a result of dividend equivalents credited with respect to the dividend on Issuer's common stock paid on January 12, 2018. Such units are payable solely in common stock and subject to the terms and conditions of the director's deferral election and the Plan. F2 · balance_after: As of January 12, 2018, Reporting Person owns options to purchase an aggregate of 23,760 shares of Issuer's common stock. Read SEC document |
| January 12, 2018 Filed Jan 16, 2018 16:16 UTC | Envision Healthcare Corp EVHC · Entity 162981 | GrantCommon Stock | 648 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001678531-18-000006 · wf-form4_151613735370139.xml · nonDerivative · entry 1 SHELTON JAMES D · CIK 0001188136 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,439 F1 · shares: Represents vested deferred stock units granted, pursuant to the Reporting Person's election, in lieu of $23,125 in cash for director fees. These deferred stock units will be settled into an equal number of shares of common stock following the earlier of the Reporting Person's termination of board service and a change in control under the Envision Healthcare Corporation 2013 Omnibus Incentive Plan. F1 · price: Represents vested deferred stock units granted, pursuant to the Reporting Person's election, in lieu of $23,125 in cash for director fees. These deferred stock units will be settled into an equal number of shares of common stock following the earlier of the Reporting Person's termination of board service and a change in control under the Envision Healthcare Corporation 2013 Omnibus Incentive Plan. Read SEC document |
| January 01, 2018 Filed Jan 3, 2018 21:31 UTC | Ventas, Inc. VTR · Entity 3044 | GrantCommon Stock | 322.863 | $60.01 | $19,375.01 |
DisclosureSEC source: 0000740260-18-000011 · wf-form4_151501506141907.xml · nonDerivative · entry 1 SHELTON JAMES D · CIK 0001188136 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,504.946 F1 · shares: Common stock in the form of units granted under the Ventas Nonemployee Directors' Deferred Stock Compensation Plan (the "Plan") in lieu of director fees pursuant to the director's deferral election. Such units are payable solely in common stock and subject to the terms and conditions of the director's deferral election and the Plan. F2 · balance_after: As of January 1, 2018, Reporting Person owns options to purchase an aggregate of 23,760 shares of Issuer's common stock. Read SEC document |
| December 07, 2017 Filed Dec 8, 2017 21:51 UTC | Ventas, Inc. VTR · Entity 3044 | GrantCommon Stock | 11.805 | $63.53 | $749.97 |
DisclosureSEC source: 0000740260-17-000161 · wf-form4_151276988397707.xml · nonDerivative · entry 1 SHELTON JAMES D · CIK 0001188136 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,182.083 F1 · shares: Common stock in the form of units granted under the Ventas Nonemployee Directors' Deferred Stock Compensation Plan (the "Plan") in lieu of director fees pursuant to the director's deferral election. Such units are payable solely in common stock and subject to the terms and conditions of the director's deferral election and the Plan. F2 · balance_after: As of December 7, 2017, Reporting Person owns options to purchase an aggregate of 23,760 shares of Issuer's common stock. Read SEC document |
| November 06, 2017 Filed Nov 7, 2017 21:46 UTC | Ventas, Inc. VTR · Entity 3044 | GrantCommon Stock | 11.702 | $64.09 | $749.98 |
DisclosureSEC source: 0000740260-17-000149 · wf-form4_151009118495557.xml · nonDerivative · entry 1 SHELTON JAMES D · CIK 0001188136 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,170.278 F1 · shares: Common stock in the form of units granted under the Ventas Nonemployee Directors' Deferred Stock Compensation Plan (the "Plan") in lieu of director fees pursuant to the director's deferral election. Such units are payable solely in common stock and subject to the terms and conditions of the director's deferral election and the Plan. F2 · balance_after: As of November 6, 2017, Reporting Person owns options to purchase an aggregate of 23,760 shares of Issuer's common stock. Read SEC document |
| October 06, 2017 Filed Oct 10, 2017 16:35 UTC | Envision Healthcare Corp EVHC · Entity 162981 | GrantCommon Stock | 309 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001678531-17-000187 · wf-form4_150766771222802.xml · nonDerivative · entry 1 SHELTON JAMES D · CIK 0001188136 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,791 F1 · shares: Represents vested deferred stock units granted, pursuant to the Reporting Person's election, in lieu of $13,750 in cash for director fees. These deferred stock units will be settled into an equal number of shares of common stock following the earlier of the Reporting Person's termination of board service and a change in control under the Envision Healthcare Holdings, Inc. 2013 Omnibus Incentive Plan. F1 · price: Represents vested deferred stock units granted, pursuant to the Reporting Person's election, in lieu of $13,750 in cash for director fees. These deferred stock units will be settled into an equal number of shares of common stock following the earlier of the Reporting Person's termination of board service and a change in control under the Envision Healthcare Holdings, Inc. 2013 Omnibus Incentive Plan. Read SEC document |
| October 01, 2017 Filed Oct 2, 2017 21:31 UTC | Ventas, Inc. VTR · Entity 3044 | GrantCommon Stock | 297.482 | $65.13 | $19,375.00 |
DisclosureSEC source: 0000740260-17-000131 · wf-form4_150697988502277.xml · nonDerivative · entry 1 SHELTON JAMES D · CIK 0001188136 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,158.576 F1 · shares: Common stock in the form of units granted under the Ventas Nonemployee Directors' Deferred Stock Compensation Plan (the "Plan") in lieu of director fees pursuant to the director's deferral election. Such units are payable solely in common stock and subject to the terms and conditions of the director's deferral election and the Plan. F2 · balance_after: Includes 103.519 units acquired on September 29, 2017 under the Plan as a result of dividend equivalents credited with respect to the dividend on Issuer's common stock paid on September 29, 2017. F3 · balance_after: As of October 1, 2017, Reporting Person owns options to purchase an aggregate of 23,760 shares of Issuer's common stock. Read SEC document |
| July 07, 2017 Filed Jul 12, 2017 17:22 UTC | Envision Healthcare Corp EVHC · Entity 162981 | GrantCommon Stock | 223 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001678531-17-000150 · wf-form4_149989450946444.xml · nonDerivative · entry 1 SHELTON JAMES D · CIK 0001188136 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,482 F1 · shares: Represents vested deferred stock units granted, pursuant to the Reporting Person's election, in lieu of $13,750 in cash for director fees. These deferred stock units will be settled into an equal number of shares of common stock following the earlier of the Reporting Person's termination of board service and a change in control under the Envision Healthcare Holdings, Inc. 2013 Omnibus Incentive Plan. F1 · price: Represents vested deferred stock units granted, pursuant to the Reporting Person's election, in lieu of $13,750 in cash for director fees. These deferred stock units will be settled into an equal number of shares of common stock following the earlier of the Reporting Person's termination of board service and a change in control under the Envision Healthcare Holdings, Inc. 2013 Omnibus Incentive Plan. Read SEC document |
| July 01, 2017 Filed Jul 5, 2017 20:29 UTC | Ventas, Inc. VTR · Entity 3044 | GrantCommon Stock | 278.857 | $69.48 | $19,374.98 |
DisclosureSEC source: 0000740260-17-000113 · wf-form4_149928656616929.xml · nonDerivative · entry 1 SHELTON JAMES D · CIK 0001188136 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,757.575 F1 · shares: Common stock in the form of units granted under the Ventas Nonemployee Directors' Deferred Stock Compensation Plan (the "Plan") in lieu of director fees pursuant to the director's deferral election. Such units are payable solely in common stock and subject to the terms and conditions of the director's deferral election and the Plan. F2 · balance_after: Includes 92.891 units acquired on June 30, 2017 under the Plan as a result of dividend equivalents credited with respect to the dividend on Issuer's common stock paid on June 30, 2017. F3 · balance_after: As of July 1, 2017, Reporting Person owns options to purchase an aggregate of 23,760 shares of Issuer's common stock. Read SEC document |
| May 25, 2017 Filed May 30, 2017 19:39 UTC | Envision Healthcare Corp EVHC · Entity 162981 | GrantCommon Stock | 3,124 | $56.03 | $175,037.72 |
DisclosureSEC source: 0001678531-17-000136 · wf-form4_149618757745613.xml · nonDerivative · entry 1 SHELTON JAMES D · CIK 0001188136 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,259 F1 · kind: Represents deferred stock units granted, pursuant to the Reporting Person's election, in lieu of the annual restricted stock unit award to non-employee directors for service on the Company's board of directors (the "Board"). The deferred stock units vest on the earlier of (i) the one-year anniversary of the grant date or (ii) the date of the Company's next annual shareholders meeting, in each case subject to continued service on the Board. Pursuant to the Reporting Person's election, once vested the settlement of these deferred stock units will be deferred until the earlier of the Reporting Person's termination of board service and a change in control of the Company. F2 · balance_after: The number of shares of common stock reported as beneficially owned by the reporting person has been reduced in order to correct a clerical error in the previous Form 4 filing. All reportable transactions have been previously reported. Read SEC document |
| May 18, 2017 Filed May 19, 2017 20:16 UTC | Ventas, Inc. VTR · Entity 3044 | GrantCommon Stock | 2,224 | $0.00 | $0.00 |
DisclosureSEC source: 0000740260-17-000097 · wf-form4_149522493366632.xml · nonDerivative · entry 1 SHELTON JAMES D · CIK 0001188136 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,385.827 F1 · shares: Restricted stock units granted by Issuer pursuant to the Ventas, Inc. 2012 Incentive Plan (the "Plan"). Such units are payable solely in common stock and subject to the terms and conditions of the director's deferral election and the Plan. These restricted stock units vest in two equal annual installments on the date of the Issuer's 2018 Annual Meeting of Stockholders and the date of the Issuer's 2019 Annual Meeting of Stockholders. F2 · balance_after: As of May 18, 2017, Reporting Person owns options to purchase an aggregate of 23,760 shares of Issuer's common stock. Read SEC document |
| April 07, 2017 Filed Apr 10, 2017 18:04 UTC | Envision Healthcare Corp EVHC · Entity 162981 | GrantCommon Stock | 229 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001678531-17-000093 · wf-form4_149186183490405.xml · nonDerivative · entry 1 SHELTON JAMES D · CIK 0001188136 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,140 F1 · shares: Represents vested deferred stock units granted, pursuant to the Reporting Person's election, in lieu of $13,750 in cash for director fees. These deferred stock units will be settled into an equal number of shares of common stock following the earlier of the Reporting Person's termination of board service and a change in control under the Envision Healthcare Holdings, Inc. 2013 Omnibus Incentive Plan. F1 · price: Represents vested deferred stock units granted, pursuant to the Reporting Person's election, in lieu of $13,750 in cash for director fees. These deferred stock units will be settled into an equal number of shares of common stock following the earlier of the Reporting Person's termination of board service and a change in control under the Envision Healthcare Holdings, Inc. 2013 Omnibus Incentive Plan. Read SEC document |
| April 01, 2017 Filed Apr 4, 2017 20:37 UTC | Ventas, Inc. VTR · Entity 3044 | GrantCommon Stock | 297.894 | $65.04 | $19,375.03 |
DisclosureSEC source: 0000740260-17-000075 · wf-form4_149133822910271.xml · nonDerivative · entry 1 SHELTON JAMES D · CIK 0001188136 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,161.827 F1 · shares: Common stock in the form of units granted under the Ventas Nonemployee Directors' Deferred Stock Compensation Plan (the "Plan") in lieu of director fees pursuant to the director's deferral election. Such units are payable solely in common stock and subject to the terms and conditions of the director's deferral election and the Plan. F2 · balance_after: Includes 94.556 units acquired on March 31, 2017 under the Plan as a result of dividend equivalents credited with respect to the dividend on Issuer's common stock paid on March 31, 2017. F3 · balance_after: As of April 1, 2017, Reporting Person owns options to purchase an aggregate of 23,760 shares of Issuer's common stock. Read SEC document |
| January 13, 2017 Filed Jan 17, 2017 16:38 UTC | Envision Healthcare Corp EVHC · Entity 162981 | GrantCommon Stock | 204 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001678531-17-000009 · wf-form4_148468907167383.xml · nonDerivative · entry 1 SHELTON JAMES D · CIK 0001188136 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,911 F1 · shares: Represents vested deferred stock units granted, pursuant to the Reporting Person's election, in lieu of $13,750 in cash for director fees. These deferred stock units will be settled into an equal number of shares of common stock following the earlier of the Reporting Person's termination of board service and a change in control under the Envision Healthcare Holdings, Inc. 2013 Omnibus Incentive Plan. F1 · price: Represents vested deferred stock units granted, pursuant to the Reporting Person's election, in lieu of $13,750 in cash for director fees. These deferred stock units will be settled into an equal number of shares of common stock following the earlier of the Reporting Person's termination of board service and a change in control under the Envision Healthcare Holdings, Inc. 2013 Omnibus Incentive Plan. Read SEC document |
| January 01, 2017 Filed Jan 4, 2017 21:48 UTC | Ventas, Inc. VTR · Entity 3044 | GrantCommon Stock | 900 | $0.00 | $0.00 |
DisclosureSEC source: 0000740260-17-000019 · wf-form4_148356652081619.xml · nonDerivative · entry 2 SHELTON JAMES D · CIK 0001188136 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,769.377 F3 · shares: Restricted stock units granted by Issuer pursuant to the Ventas, Inc. 2012 Incentive Plan (the "Plan"). Such units are payable solely in common stock and subject to the terms and conditions of the director's deferral election and the Plan. These restricted stock units vest in two equal annual installments beginning on the first anniversary of the date of the grant. F4 · balance_after: As of January 1, 2017, Reporting Person owns options to purchase an aggregate of 23,760 shares of Issuer's common stock. Read SEC document |
| January 01, 2017 Filed Jan 4, 2017 21:48 UTC | Ventas, Inc. VTR · Entity 3044 | GrantCommon Stock | 309.901 | $62.52 | $19,375.01 |
DisclosureSEC source: 0000740260-17-000019 · wf-form4_148356652081619.xml · nonDerivative · entry 1 SHELTON JAMES D · CIK 0001188136 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,869.377 F1 · shares: Common stock in the form of units granted under the Ventas Nonemployee Directors' Deferred Stock Compensation Plan (the "Deferred Plan") in lieu of director fees pursuant to the director's deferral election. Such units are payable solely in common stock and subject to the terms and conditions of the director's deferral election and the Deferred Plan. F2 · balance_after: Includes 93.368 units acquired on December 30, 2016 under the Deferred Plan as a result of dividend equivalents credited with respect to the dividend on Issuer's common stock paid on December 30, 2016. Read SEC document |
| December 30, 2016 Filed Jan 4, 2017 16:58 UTC | Envision Healthcare Corp EVHC · Entity 162981 | GrantCommon Stock | 221 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001678531-17-000005 · wf-form4_148356708054970.xml · nonDerivative · entry 1 SHELTON JAMES D · CIK 0001188136 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,707 F1 · shares: Represents vested deferred stock units granted, pursuant to the Reporting Person's election, in lieu of $14,000 in cash for director fees. These deferred stock units will be settled into an equal number of shares of common stock following the earlier of the Reporting Person's termination of board service and a change in control under the Envision Healthcare Holdings, Inc. 2013 Omnibus Incentive Plan. F1 · price: Represents vested deferred stock units granted, pursuant to the Reporting Person's election, in lieu of $14,000 in cash for director fees. These deferred stock units will be settled into an equal number of shares of common stock following the earlier of the Reporting Person's termination of board service and a change in control under the Envision Healthcare Holdings, Inc. 2013 Omnibus Incentive Plan. Read SEC document |
| December 07, 2016 Filed Dec 8, 2016 22:50 UTC | Ventas, Inc. VTR · Entity 3044 | GrantCommon Stock | 12.058 | $62.20 | $750.01 |
DisclosureSEC source: 0000740260-16-000351 · wf-form4_148123739587823.xml · nonDerivative · entry 1 SHELTON JAMES D · CIK 0001188136 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,466.108 F1 · shares: Common stock in the form of units granted under the Ventas Nonemployee Directors' Deferred Stock Compensation Plan (the "Plan") in lieu of director fees pursuant to the director's deferral election. Such units are payable solely in common stock and subject to the terms and conditions of the director's deferral election and the Plan. F2 · balance_after: As of December 7, 2016, Reporting Person owns options to purchase an aggregate of 23,760 shares of Issuer's common stock. Read SEC document |
| December 01, 2016 Filed Dec 1, 2016 19:07 UTC | Envision Healthcare Holdings, Inc. EVHC · Entity 180702 | Disposition to issuerCommon Stock | 10,435 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-16-152789 · doc4.xml · nonDerivative · entry 1 SHELTON JAMES D · CIK 0001188136 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · kind: Disposition pursuant to the terms of the Agreement and Plan of Merger, dated as of June 15, 2016, by and among Envision Healthcare Holdings, Inc., New Amethyst Corp. and AmSurg Corp. (the "Merger Agreement"), exempt under Rule 16b-3. F2 · shares: Pursuant to the terms of the Merger Agreement, at the Merger 2 Effective Time, each deferred stock unit held by the reporting person immediately prior to the Merger 2 Effective Time (as defined in the Merger Agreement) was assumed by New Amethyst and converted into a New Amethyst deferred stock unit having the same terms and conditions, taking into account any changes thereto by reason of the Mergers (as defined in the Merger Agreement). F2 · price: Pursuant to the terms of the Merger Agreement, at the Merger 2 Effective Time, each deferred stock unit held by the reporting person immediately prior to the Merger 2 Effective Time (as defined in the Merger Agreement) was assumed by New Amethyst and converted into a New Amethyst deferred stock unit having the same terms and conditions, taking into account any changes thereto by reason of the Mergers (as defined in the Merger Agreement). Read SEC document |
| December 01, 2016 Filed Dec 2, 2016 17:03 UTC | Envision Healthcare Corp EVHC · Entity 162981 | GrantCommon Stock | 3,486 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001678531-16-000084 · wf-form4_148071622297658.xml · nonDerivative · entry 1 SHELTON JAMES D · CIK 0001188136 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,486 F1 · price: Acquisition pursuant to the terms of the Agreement and Plan of Merger, dated as of June 15, 2016, by and among Envision Healthcare Holdings, Inc., Envision Healthcare Corporation (formerly known as New Amethyst Corp.) (the "Company") and AmSurg Corp. (the "Merger Agreement"), exempt under Rule 16b-3. F2 · price: Pursuant to the terms of the Merger Agreement, at the Merger 2 Effective Time (as defined in the Merger Agreement), each share of Envision Healthcare Holdings, Inc. common stock held by the reporting person immediately prior to the Merger 2 Effective Time was assumed by the Company and converted into 0.334 shares of the Company's common stock having the same terms and conditions, taking into account any changes thereto by reason of the Mergers (as defined in the Merger Agreement). F3 · price: Pursuant to the Merger Agreement, equity-based awards granted pursuant to Envision Healthcare Holdings plans that were outstanding immediately prior to the effective time of the Mergers were converted into corresponding awards in respect of the Company's common stock at the effective time of the Mergers, subject to the same terms and conditions (including applicable vesting requirements) as were applicable to such awards prior to the consummation of the Mergers; provided, that equity-based awards granted pursuant to Envision Healthcare Holdings plans were adjusted to reflect the Exchange Ratio (as defined in the Merger Agreement). Read SEC document |
| November 17, 2016 Filed Nov 17, 2016 22:03 UTC | Ventas, Inc. VTR · Entity 3044 | GrantCommon Stock | 12.59 | $59.57 | $749.99 |
DisclosureSEC source: 0000740260-16-000343 · wf-form4_147942018620748.xml · nonDerivative · entry 1 SHELTON JAMES D · CIK 0001188136 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,454.05 F1 · shares: Common stock in the form of units granted under the Ventas Nonemployee Directors' Deferred Stock Compensation Plan (the "Plan") in lieu of director fees pursuant to the director's deferral election. Such units are payable solely in common stock and subject to the terms and conditions of the director's deferral election and the Plan. F2 · balance_after: As of November 17, 2016, Reporting Person owns options to purchase an aggregate of 23,760 shares of Issuer's common stock. Read SEC document |
| October 01, 2016 Filed Oct 3, 2016 20:29 UTC | Ventas, Inc. VTR · Entity 3044 | GrantCommon Stock | 274.317 | $70.63 | $19,375.01 |
DisclosureSEC source: 0000740260-16-000320 · wf-form4_147552658553479.xml · nonDerivative · entry 1 SHELTON JAMES D · CIK 0001188136 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,441.46 F1 · shares: Common stock in the form of units granted under the Ventas Nonemployee Directors' Deferred Stock Compensation Plan (the "Plan") in lieu of director fees pursuant to the director's deferral election. Such units are payable solely in common stock and subject to the terms and conditions of the director's deferral election and the Plan. F2 · balance_after: Includes 73.994 units acquired on September 30, 2016 under the Plan as a result of dividend equivalents credited with respect to the dividend on Issuer's common stock paid on September 30, 2016. F3 · balance_after: As of October 3, 2016, Reporting Person owns options to purchase an aggregate of 23,760 shares of Issuer's common stock. Read SEC document |
| September 30, 2016 Filed Oct 4, 2016 16:37 UTC | Envision Healthcare Holdings, Inc. EVHC · Entity 180702 | GrantCommon Stock | 634 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-16-144298 · doc4.xml · nonDerivative · entry 1 SHELTON JAMES D · CIK 0001188136 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,435 F1 · shares: Represents vested deferred stock units granted, pursuant to the Reporting Person's election, in lieu of $14,125 in cash for director fees. These deferred stock units will be settled into an equal number of shares of common stock following the earlier of the Reporting Person's termination of board service and a change in control under the Envision Healthcare Holdings, Inc. 2013 Omnibus Incentive Plan. F1 · price: Represents vested deferred stock units granted, pursuant to the Reporting Person's election, in lieu of $14,125 in cash for director fees. These deferred stock units will be settled into an equal number of shares of common stock following the earlier of the Reporting Person's termination of board service and a change in control under the Envision Healthcare Holdings, Inc. 2013 Omnibus Incentive Plan. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.